Surgical site infection (SSI) is a significant cause of postoperative morbidity and mortality, increasing length of hospital stay and cost of care. 1-3 SSIs are the second most common cause of health care associated infection; U.S. studies have estimated a $45 billion annual cost. 4
of chlorhexidine (CHG) or povidone-iodine (PVI) is more effective. Several meta-analyses have been published, with no comprehensive conclusion in favor of one or the other. [6] [7] [8] [9] [10] CHG and PVI have different mechanisms of action and different spectrums of efficacy. Their simultaneous application was thought to form a less effective cocktail, although this belief has recently been challenged in vitro, with evidence in fact for a potential synergistic effect. 11 Regardless, sequential application would circumvent such concerns.
In clinical practice, therefore, no single chemical containing both CHG and PVI has been available. However, perhaps following the logic that "more is less" or covering all bases in the debate of CHG versus PVI, anecdotally and despite little scientific study of the method, many surgeons use a combination of CHG preparation and PVI preparation in sequence.
Our objectives therefore were to perform a systematic review and meta-analysis to consider the evidence for combination CHG and PVI antisepsis. Specifically, we aimed to study if combination skin preparation (1) reduces SSI compared with single-agent use and (2) reduces colonization at the operative site.
Methods
Systematic Review MEDLINE (Ovid), Embase (Ovid), and Cochrane database of clinical trials (Ovid) were searched on April 1, 2015, using the search strategy ("Surgical site infection" OR "Surgical Wound Infection") AND ("Chlorhexidine") AND ("Iodine" OR "Iodine Compounds" OR "Povidone-Iodine" OR "Idophor") adapted from Dumville et al. 6 A single reviewer screened resulting abstracts to select studies where a combination of CHG and PVI had been used. If unclear from the abstract alone, the full publication was sought. References from the short-listed abstracts were additionally screened for relevant studies. A second reviewer then rechecked this short list. Their quality of evidence was assessed by each reviewer independently and graded using the Oxford Levels of Evidence criteria. 12 Any disagreement was resolved by common discussion.
Meta-Analysis
The primary outcome for the meta-analysis was SSI. The secondary outcome was decolonization at the operative site. For the meta-analysis, comparative, human trials comparing the use of combination CHG and PVI, as preoperative (i.e., just prior to incision) antisepsis, to singleagent CHG or PVI use were included. Studies were excluded if the use or absence of alcohol was inconsistent between arms of the study. Two reviewers assessed eligibility independently and any disagreement was resolved through discussion and mutual agreement. Assessment of bias was also conducted by each reviewer independently, using the criteria set out by Higgins et al. 13 This information was analyzed in combination with the GRADE profiling method, using GRADEpro (Evidence Prime, Hamilton, Ontario, Canada) to assess the overall quality of evidence relating to our primary and secondary outcomes. 14 Pooled analysis was conducted using Revman V5.3 (Cochrane Collaborative, Copenhagen, Denmark). Study heterogeneity was assessed using the Cochrane Q test, where p < 0.05 indicated significant heterogeneity and pooled odds ratios (ORs), with 95% confidence intervals (CIs), were calculated to assess overall effect.
Results
A PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram for our search methodology and results is presented in ►Fig. 1. This strategy identified 18 publications where a combination of CHG and PVI had been used (►Table 1). 1, 11, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Only four of these publications were eligible for the meta-analysis. [24] [25] [26] 30 Of the excluded but short-listed studies, 12/14 offered some indication of a role for combination CHG and PVI skin preparation, including 3 studies detailing the implementation of a bundle of care requiring combination skin preparation, 16,22,23 1 letter in favor of its use, 20 5 clinical trials where combination skin preparation was standard practice in both arms, 17,19,27-29 1 trial in favor of combination CHG and PVI for preoperative nasal decolonisation, 21 1 trial in favor for central line insertion, 1 and 1 basic science study. 11 Only 1 study suggested the combination provided no additional benefit. 18 These publications were considered level 5 evidence.
Primary Objective: Does Combination Skin Preparation Reduce Surgical Site Infection Rates?
Only 1 of the 4 eligible studies reported SSI as the outcome. This study was a conference abstract of a randomized controlled trial (RCT) of 1,404 women undergoing cesarean section to preoperative antisepsis with PVI, CHG, or combination CHG and PVI by Ngai et al. 26 During analysis, the article was subsequently published in full. 31 The study identified SSI incidences of 4.6% PVI, 4.5% CHG, and 3.9% CHG and PVI. This difference was not significant. However, on performing subgroup analysis of class III obese women, a combination of CHG and PVI was demonstrated to reduce SSI in a multivariate model (OR 0.17, CI 0.04 to 0.77).
Secondary Objective: Does Combination Skin Preparation Reduce Bacterial Colonization at the Operative Site?
The remaining three studies reported bacterial colonization as their outcome. 24, 25, 30 The quality of evidence had a moderate to high risk of bias, given the methodologies were susceptible to selection, performance, and detection bias (►Fig. 2). Specific discrepancies included the tissue choice (grafted skin tissue, 25 regular skin, 24 and the umbilicus 30 ), the application (CHG/alcohol/PVI, 25 CHG/PVI/PVI, 24 and PVIsoaked sponge for 1 hour/CHG with alcohol 30 ), and the control preparation (►Table 2).
In addition, it was often unclear as to whether adequate precautions had been taken to neutralize the samples during bacterial counting.
The outcomes of these studies also differed, but they all reported the proportion of individual patients yielding no
The Surgery Journal Vol. 2 No. 3/2016 growth. Overall, therefore the result for 547 patients could be pooled for analysis.
Complete decolonization rates were greatest for combination CHG and PVI (90%), compared with CHG (65%) or PVI (47%) alone, and yielded a pooled OR for complete decolonization of 5.62 (95% CI 3.2 to 9.7, p < 0.00001) in favor of combination CHG and PVI skin preparation (►Fig. 3). There was no evidence of heterogeneity (Cochran's Q 2.1, 2 df,
Discussion
At present, only a single high-quality RCT has considered the effect of a combination of CHG and PVI with some promise. The evidence for improved bacterial decolonization with a combination of PVI and CHG is perhaps firmer.
Although a reduction in SSI is a logical result of greater bacterial decolonization, studies have reported contradicting examples. 32, 33 The relative infrequency of SSI has led to the acceptance of surrogate markers such as skin cultures, 34 but their association with SSI is not well validated. 7 As a multifactorial problem, it is likely that the effect was hidden, but it poses a hurdle for future investigation. 34 This difficulty can be seen in the RCT by Ngai et al. 31 During their study, they found an unexpected low incidence of SSI, which resulted in an underpowered study. Post hoc analysis suggested a sample size of 3,000 would have been required to detect a significant difference. 31 Although such a large-scale study would be unusual in surgery, the requirement for improved methods of combatting SSI is clear. SSI significantly contributes to postoperative morbidity and mortality, and with worsening antibiotic resistance, it could become more pertinent. Powering to detect a 0.5% improvement therefore has major implications, when its extrapolation across different fields of surgery all around the globe is considered.
An additional question to be answered is whether the efficacy of combination skin preparation draws on the intrinsic requirement for the skin to be cleaned twice rather than the agent itself. There is some evidence to suggest this factor is not significant: May et al controlled for this eventuality when comparing PVI with CHG and PVI, 25 36 Placing our findings within the existing body of literature is difficult, given its paucity. The pooled analysis identified that PVI was less effective than CHG, which reassuringly is in keeping with consensus from the literature. 6, 8 Additionally, the greater efficacy of combination CHG and PVI mirrors findings from other types of antisepsis and its incorporation into successful bundles of perioperative care. 1, 16, 22, 23 On the background of our findings from this systematic review, we have conducted a retrospective assessment of our neurosurgical surveillance data from a single center. 37 In a multivariate model, we identified a greater than fivefold benefit for combination CHG and PVI (OR 0.12, CI 0.02 to 0.63). Mechanistically, there is good reason to believe combination CHG and PVI would be of benefit. First, although both have a broad spectrum of antibacterial activity, PVI can also target viruses, fungi, and bacterial spores, and CHG can target yeast. Second, the action of PVI is intracellular, and therefore the action of CHG, which disrupts cell membranes, would theoretically augment its potency. And finally, PVI has a more immediate action than CHG, which is delayed. 11, 38 
Conclusion
Further advances in the battle to prevent SSI are required as its significant impact is well recognized. Bacterial decolonization at the operative site is more effective when the combination is used. Although there is presently no level 1 evidence demonstrating a definitive effect of combination CHG and PVI for reducing SSI, building on promising mechanism-based reasoning, basic science data, and its incorporation into successful bundles of care, the use of combination CHG and PVI has shown promise in a large RCT. Further study is warranted. 
